The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Selective Activation of p38 Mitogen-activated Protein (MAP) Kinase Isoforms by the MAP Kinase Kinases MKK3 and MKK6
Open accessAbstract
The cellular response to treatment with proinflammatory cytokines or exposure to environmental stress is mediated, in part, by the p38 group of mitogen-activated protein (MAP) kinases. We report the molecular cloning of a novel isoform of p38 MAP kinase, p38 beta 2. This p38 MAP kinase, like p38 alpha, is inhibited by the pyridinyl imidazole drug SB203580. The p38 MAP kinase kinase MKK6 is identified as a common activator of p38 alpha, p38 beta 2, and p38 gamma MAP kinase isoforms, while MKK3 activates only p38 alpha and p38 gamma MAP kinase isoforms. The MKK3 and MKK6 signal transduction pathways are therefore coupled to distinct, but overlapping, groups of p38 MAP kinases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Site-directed mutagenesis by overlap extension using the polymerase chain reaction
Ho, S. N., Hunt, H. D., Horton, R. M., Pullen, J. K., & Pease, L. R. (1989) · Gene · doi:10.1016/0378-1119(89)90358-2 · Cited by 7,399
Smith, D. B., & Johnson, K. S. (1988) · Gene · doi:10.1016/0378-1119(88)90005-4 · Cited by 5,892
A protein kinase involved in the regulation of inflammatory cytokine biosynthesis
Lee, J. C., Laydon, J. T., McDonnell, P. C., Gallagher, T. F., Kumar, S., Green, D., McNulty, D., Blumenthal, M. J., Keys, J. R., Land vatter, S. W., et al. (1994) · Nature · doi:10.1038/372739a0 · Cited by 3,288
Dérijard, B., Hibi, M., Wu, I.-H., Barrett, T., Su, B., Deng, T., Karin, M., & Davis, R. J. (1994) · Cell · doi:10.1016/0092-8674(94)90380-8 · Cited by 3,188
Self-citationA MAP Kinase Targeted by Endotoxin and Hyperosmolarity in Mammalian Cells
Han, J., Lee, J.-D., Bibbs, L., & Ulevitch, R. J. (1994) · Science · doi:10.1126/science.7914033 · Cited by 2,646
Mitogen-activated protein kinase pathways
Robinson, M. J., & Cobb, M. H. (1997) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(97)80061-0 · Cited by 2,474
Ichijo, H., Nishida, E., Irie, K., Dijke, P. T., Saitoh, M., Moriguchi, T., Takagi, M., Matsumoto, K., Miyazono, K., & Gotoh, Y. (1997) · Science · doi:10.1126/science.275.5296.90 · Cited by 2,307
Raingeaud, J., Gupta, S., Rogers, J. S., Dickens, M., Han, J., Ulevitch, R. J., & Davis, R. J. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.13.7420 · Cited by 2,241
Self-citationThe mitogen-activated protein kinase signal transduction pathway
Davis, R. J. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)82362-6 · Cited by 2,139
Self-citation(1995) · FEBS Letters · doi:10.1016/0014-5793(95)00357-f · Cited by 2,086
Cited by
Activation and signaling of the p38 MAP kinase pathway
ZARUBIN, T., & HAN, J. (2005) · Cell Research · doi:10.1038/sj.cr.7290257 · Cited by 1,707
Mechanisms and functions of p38 MAPK signalling
Cuadrado, A., & Nebreda, A. R. (2010) · Biochemical Journal · doi:10.1042/bj20100323 · Cited by 1,676
The p38 signal transduction pathway Activation and function
Ono, K., & Han, J. (2000) · Cellular Signalling · doi:10.1016/s0898-6568(99)00071-6 · Cited by 1,571
Aguirre, V., Uchida, T., Yenush, L., Davis, R., & White, M. F. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.12.9047 · Cited by 1,487
Self-citationDifferential regulation and properties of MAPKs
Raman, M., Chen, W., & Cobb, M. H. (2007) · Oncogene · doi:10.1038/sj.onc.1210392 · Cited by 1,430
p38 MAP-Kinases pathway regulation, function and role in human diseases
Cuenda, A., & Rousseau, S. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2007.03.010 · Cited by 1,400
Freund, A., Patil, C. K., & Campisi, J. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.69 · Cited by 1,039
Chen, Z., Gibson, T. B., Robinson, F., Silvestro, L., Pearson, G., Xu, B.-E., Wright, A., Vanderbilt, C., & Cobb, M. H. (2001) · Chemical Reviews · doi:10.1021/cr000241p · Cited by 788
Madrid, L. V., Mayo, M. W., Reuther, J. Y., & Baldwin, A. S. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101103200 · Cited by 777
TNF receptor subtype signalling: Differences and cellular consequences
MacEwan, D. J. (2002) · Cellular Signalling · doi:10.1016/s0898-6568(01)00262-5 · Cited by 610
p38 MAP kinase inhibition enables proliferation of adult mammalian cardiomyocytes
Engel, F. B., Schebesta, M., Duong, M. T., Lu, G., Ren, S., Madwed, J. B., Jiang, H., Wang, Y., & Keating, M. T. (2005) · Genes & Development · doi:10.1101/gad.1306705 · Cited by 595
Lu, J., McKinsey, T. A., Zhang, C.-L., & Olson, E. N. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)00025-3 · Cited by 547
Lu, J., McKinsey, T. A., Nicol, R. L., & Olson, E. N. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.080064097 · Cited by 518
Essential Role of p38α MAP Kinase in Placental but Not Embryonic Cardiovascular Development
Adams, R. H., Porras, A., Alonso, G., Jones, M., Vintersten, K., Panelli, S., Valladares, A., Perez, L., Klein, R., & Nebreda, A. R. (2000) · Molecular Cell · doi:10.1016/s1097-2765(05)00014-6 · Cited by 516
Kinases that control the cell cycle in response to DNA damage: Chk1, Chk2, and MK2
Reinhardt, H. C., & Yaffe, M. B. (2009) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2009.01.018 · Cited by 497
Mielke, K., & Herdegen, T. (2000) · Progress in Neurobiology · doi:10.1016/s0301-0082(99)00042-8 · Cited by 490
Role of p38 MAP Kinase Signal Transduction in Solid Tumors
Koul, H. K., Pal, M., & Koul, S. (2013) · Genes & Cancer · doi:10.1177/1947601913507951 · Cited by 484
p38 Mitogen-activated Protein Kinase Pathway Promotes Skeletal Muscle Differentiation
Zetser, A., Gredinger, E., & Bengal, E. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.8.5193 · Cited by 461
Inhibition of p38 MAP kinase as a therapeutic strategy
Lee, J. C., Kumar, S., Griswold, D. E., Underwood, D. C., Votta, B. J., & Adams, J. L. (2000) · Immunopharmacology · doi:10.1016/s0162-3109(00)00206-x · Cited by 455
Mahtani, K. R., Brook, M., Dean, J. L. E., Sully, G., Saklatvala, J., & Clark, A. R. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.9.6461-6469.2001 · Cited by 448
Aguirre-Ghiso, J. A., Liu, D., Mignatti, A., Kovalski, K., & Ossowski, L. (2001) · Molecular Biology of the Cell · doi:10.1091/mbc.12.4.863 · Cited by 446
The p38 MAPK inhibitors for the treatment of inflammatory diseases and cancer
Yong, H.-Y., Koh, M.-S., & Moon, A. (2009) · Expert Opinion on Investigational Drugs · doi:10.1517/13543780903321490 · Cited by 422
Map kinase signaling pathways and hematologic malignancies
Platanias, L. C. (2003) · Blood · doi:10.1182/blood-2002-12-3647 · Cited by 432
The complexity of mitogen-activated protein kinases (MAPKs) made simple
Krishna, M., & Narang, H. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-8170-7 · Cited by 432
Bakin, A. V., Rinehart, C., Tomlinson, A. K., & Arteaga, C. L. (2002) · Journal of Cell Science · doi:10.1242/jcs.115.15.3193 · Cited by 431
Interferon-gamma expression by Th1 effector T cells mediated by the p38 MAP kinase signaling pathway
Rincon, M. (1998) · The EMBO Journal · doi:10.1093/emboj/17.10.2817 · Cited by 417
The p38 MAPK pathway is essential for skeletogenesis and bone homeostasis in mice
Greenblatt, M. B., Shim, J.-H., Zou, W., Sitara, D., Schweitzer, M., Hu, D., Lotinun, S., Sano, Y., Baron, R., Park, J. M., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci42285 · Cited by 414
Self-citationThe p38 Pathway: From Biology to Cancer Therapy
Martínez-Limón, A., Joaquin, M., Caballero, M., Posas, F., & de Nadal, E. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21061913 · Cited by 411
TNF ligands and receptors – a matter of life and death
MacEwan, D. J. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704549 · Cited by 391
Defective IL-12 production in mitogen-activated protein (MAP) kinase kinase 3(Mkk3)-deficient mice
Lu, H.-T. (1999) · The EMBO Journal · doi:10.1093/emboj/18.7.1845 · Cited by 384
Goh, K. C. (1999) · The EMBO Journal · doi:10.1093/emboj/18.20.5601 · Cited by 379
Wang, W., Chen, J. X., Liao, R., Deng, Q., Zhou, J. J., Huang, S., & Sun, P. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.10.3389-3403.2002 · Cited by 376
Essential role for p38α mitogen-activated protein kinase in placental angiogenesis
Mudgett, J. S., Ding, J., Guh-Siesel, L., Chartrain, N. A., Yang, L., Gopal, S., & Shen, M. M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.180316397 · Cited by 372
Specific Inhibitors of p38 Mitogen-activated Protein Kinase Block 3T3-L1 Adipogenesis
Engelman, J. A., Lisanti, M. P., & Scherer, P. E. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.48.32111 · Cited by 360
MAP kinase pathways activated by stress: The p38 MAPK pathway
Obata, T., Brown, G. E., & Yaffe, M. B. (2000) · Critical Care Medicine · doi:10.1097/00003246-200004001-00008 · Cited by 357
p38 Mitogen-Activated Protein Kinase Inhibitors— Mechanisms and Therapeutic Potentials
Lee, J. C., Kassis, S., Kumar, S., Badger, A., & Adams, J. L. (1999) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(99)00008-x · Cited by 348
p38 MAPK and NF-κB Collaborate to Induce Interleukin-6 Gene Expression and Release
Craig, R., Larkin, A., Mingo, A. M., Thuerauf, D. J., Andrews, C., McDonough, P. M., & Glembotski, C. C. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m909695199 · Cited by 339
Ets ternary complex transcription factors
Buchwalter, G., Gross, C., & Wasylyk, B. (2004) · Gene · doi:10.1016/j.gene.2003.09.028 · Cited by 336
p38 MAP kinase: a convergence point in cancer therapy
Olson, J. M., & Hallahan, A. R. (2004) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2004.01.007 · Cited by 335
The in vivo role of p38 MAP kinases in cardiac remodeling and restrictive cardiomyopathy
Liao, P., Georgakopoulos, D., Kovacs, A., Zheng, M., Lerner, D., Pu, H., Saffitz, J., Chien, K., Xiao, R.-P., Kass, D. A., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.211086598 · Cited by 333
Braz, J. C., Bueno, O. F., Liang, Q., Wilkins, B. J., Dai, Y.-S., Parsons, S., Braunwart, J., Glascock, B. J., Klevitsky, R., Kimball, T. F., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17295 · Cited by 332
Signalling for survival and death in neurones: the role of stress-activated kinases, JNK and p38
Harper, S. J., & LoGrasso, P. (2001) · Cellular Signalling · doi:10.1016/s0898-6568(01)00148-6 · Cited by 304
Keum, Y.-S., Yu, S., Chang, P. P.-J., Yuan, X., Kim, J.-H., Xu, C., Han, J., Agarwal, A., & Kong, A.-N. T. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3513 · Cited by 303
Differential targeting of MAP kinases to the ETS-domain transcription factor Elk-1
Yang, S.-H. (1998) · The EMBO Journal · doi:10.1093/emboj/17.6.1740 · Cited by 299
Kumar, S., Jiang, M. S., Adams, J. L., & Lee, J. C. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1454 · Cited by 299
Liou, A. K. F., Clark, R. S., Henshall, D. C., Yin, X.-M., & Chen, J. (2003) · Progress in Neurobiology · doi:10.1016/s0301-0082(03)00005-4 · Cited by 297
Gratton, J.-P., Morales-Ruiz, M., Kureishi, Y., Fulton, D., Walsh, K., & Sessa, W. C. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m009698200 · Cited by 281
The p38 mitogen-activated protein kinase (MAPK) pathway in rheumatoid arthritis
Schett, G., Zwerina, J., & Firestein, G. (2008) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2007.074278 · Cited by 271
Deficiency of the Stress Kinase P38α Results in Embryonic Lethality
Allen, M., Svensson, L., Roach, M., Hambor, J., McNeish, J., & Gabel, C. A. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.5.859 · Cited by 268
Regulation of Mitogen-Activated Protein Kinase Signaling Networks by G Protein-Coupled Receptors
Gutkind, J. S. (2000) · Science's STKE · doi:10.1126/stke.2000.40.re1 · Cited by 264
Turkson, J., Bowman, T., Adnane, J., Zhang, Y., Djeu, J. Y., Sekharam, M., Frank, D. A., Holzman, L. B., Wu, J., Sebti, S., et al. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.11.7519 · Cited by 258
Targeting of p38 Mitogen-Activated Protein Kinases to MEF2 Transcription Factors
Yang, S.-H., Galanis, A., & Sharrocks, A. D. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.6.4028 · Cited by 244
Elk-1 a Transcription Factor with Multiple Facets in the Brain
Besnard, A., Galan-Rodriguez, B., Vanhoutte, P., & Caboche, J. (2011) · Frontiers in Neuroscience · doi:10.3389/fnins.2011.00035 · Cited by 195
Corazzari, M., Rapino, F., Ciccosanti, F., Giglio, P., Antonioli, M., Conti, B., Fimia, G. M., Lovat, P. E., & Piacentini, M. (2015) · Cell Death & Differentiation · doi:10.1038/cdd.2014.183 · Cited by 162
Alsayed, Y., Uddin, S., Mahmud, N., Lekmine, F., Kalvakolanu, D. V., Minucci, S., Bokoch, G., & Platanias, L. C. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m007431200 · Cited by 161
Uddin, S., Ah-Kang, J., Ulaszek, J., Mahmud, D., & Wickrema, A. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307075101 · Cited by 151
Caffrey, D. R., O'Neill, L. A. J., & Shields, D. C. (1999) · Journal of Molecular Evolution · doi:10.1007/pl00006578 · Cited by 124
Ferrer, I., Barrachina, M., Tolnay, M., Rey, M. J., Vidal, N., Carmona, M., Blanco, R., & Puig, B. (2003) · Brain Pathology · doi:10.1111/j.1750-3639.2003.tb00007.x · Cited by 60
P38β MAPK Upregulates Atrogin1/MAFbx by Specific Phosphorylation of C/EBPβ
Zhang, G., & Li, Y.-P. (2012) · Skeletal Muscle · doi:10.1186/2044-5040-2-20 · Cited by 53
Liu, K., Lin, Y., Rao, T., Huang, Y., Kan, Y., & Liao, J. (2025) · Journal of Orthopaedic Surgery and Research · doi:10.1186/s13018-025-05986-8 · Cited by 11
Molecular characterization of a zebrafish TCF ETS-domain transcription factor
Brown, L. A., Yang, S.-H., Hair, A., Galanis, A., & Sharrocks, A. D. (1999) · Oncogene · doi:10.1038/sj.onc.1203197 · Cited by 10
Metadata
- Authors
- Enslen, H., Raingeaud, J., & Davis, R. J.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 1998-01
- Volume
- 273
- Issue
- 3
- Pages
- 1741-1748
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2082355820
- Cited by
- 539
- References
- 57
- FWCI
- 16.32
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.